ArticleLung cancer (Amsterdam, Netherlands)2025

The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.

Tejas Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.